Is DiaSorin S.p.A. (DSRLF) a Buy, Sell, or Hold?
OTC : DSRLF
DiaSorin S.p.A.
$81 USD
$0 (0.0%)
- Volume
- 1K
- Average Volume
- 116
- Market Capitalization
- $4.01B
- P/E Ratio
- 23.53
- Dividend Yield
- 1.72%
- Price Target
- Year High
- $107.68
- Year Low
- $66.50
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.30
- Current Ratio
- $0.00
Company Overview
OTC
Carlo Rosa
Medical - Diagnostics & Research
Healthcare
DSRLF
3272
IT
USD
Liquidity Metrics
0.47
0.00
0.00
0.00
0.30
Sales & Valuation
$1.19B
2.14
2.82
9.75
6.85
Profitability
$2.77
$155.62M
12.11%
16.83%
13.66%
8.56%
P/E Metrics
23.53
-0.88
-0.88
Analyst Price Target & Rating
2/5
4 Analysts
%
Financial Health Scores
3.54
4/9
$343M
$2.47B
$972M
$392.1M
Key Metrics (TTM)
$4.41B
2.53
9.31
0.00
13.66%
8.04%
5.05%
10.36%
$47.68
0 days
Company Executives
| Name | Title |
|---|---|
| Chen Menachem Even | Chief Commercial Officer, Senior Corporate Vice President of Commercial Operations & Executive Director |
| Carlo Rosa | Chief Executive Officer, GM & Executive Director |
| Ulisse Spada | Corporate Vice President, Head of the Legal Department, Secretary & General Counsel |
| Amelia Parente | Senior Corporate Vice President of Human Resources |
| Alberto Donati | Chief Financial Officer |
| Riccardo Fava | Corporate Vice President of Communication, ESG & Investor Relations |
| Alberto Campani | Chief Executive Officer, GM of Diasorin Italy & Vice President of Global Immuno Operations |
| Fabrizio Bonelli | Chief Scientific Officer |
| Luigi Cicchese | Senior Corporate Vice President of Systems & Engineering |
| Rita Maffei | Senior Corporate Vice President of Quality, Regulatory & Clinical Affairs |
Poll Results
No votes yet today — be the first to share your view!
About DiaSorin S.p.A. (OTC:DSRLF) Stock
Established in 1968 and based in Saluggia, Italy, DiaSorin S.p.A. is a prominent player in the global diagnostics market. The company specializes in the creation, production, and distribution of sophisticated immunodiagnostic and molecular diagnostic testing kits. Its extensive reach spans across Europe, Africa, North, Central, and South America, the Asia Pacific region, and China. Among its offerings, DiaSorin provides a range of LIAISON platforms for immunodiagnostics, including the LIAISON XS, LIAISON XL, and LIAISON XL LAS systems. For molecular diagnostics, the LIAISON MDX platform is key, designed to amplify nucleic acids for identifying viruses in patient biological samples, thereby enabling the diagnosis of viral infections. DiaSorin also actively engages in strategic alliances to ... expand its diagnostic capabilities. These include a partnership with QIAGEN for a latent tuberculosis detection solution, a collaboration with TTP to develop molecular Point-of-Care solutions, and an agreement with MeMed to introduce a test that distinguishes between viral and bacterial infections.
DiaSorin S.p.A. (DSRLF) Q2 2026 Earnings Call Transcript
2026-08-01 00:23:09
DiaSorin S.p.A. (DSRLF) Q2 2026 Earnings Call Transcript
DiaSorin S.p.A. (DSRLF) Q1 2026 Earnings Call Transcript
2026-05-08 18:21:15
DiaSorin S.p.A. (DSRLF) Q1 2026 Earnings Call Transcript
Frequently Asked Questions
-
What is the current DiaSorin S.p.A. (DSRLF) stock price?
-
DiaSorin S.p.A.(OTC:DSRLF) stock price is $81 in the last trading session. During the trading session, DSRLF stock reached the peak price of $107.68 while $66.5 was the lowest point it dropped to. The percentage change in DSRLF stock occurred in the recent session was 0.0% while the dollar amount for the price change in DSRLF stock was $0.
-
DSRLF's industry and sector of operation?
-
The OTC listed DSRLF is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.
-
Who are the executives of DSRLF?
-
Chen Menachem Even | Chief Commercial Officer, Senior Corporate Vice President of Commercial Operations & Executive Director
Carlo Rosa | Chief Executive Officer, GM & Executive Director
Ulisse Spada | Corporate Vice President, Head of the Legal Department, Secretary & General Counsel
Amelia Parente | Senior Corporate Vice President of Human Resources
Alberto Donati | Chief Financial Officer -
How many employees does DSRLF have?
-
Number of DSRLF employees currently stands at 3272. DSRLF operates from Via Crescentino snc, Saluggia, VC 13040, IT.
-
Link for DSRLF official website?
-
Official Website of DSRLF is: https://int.diasorin.com
-
How do I contact DSRLF?
-
DSRLF could be contacted at phone #39 01 614871 and can also be accessed through its website. DSRLF operates from Via Crescentino snc, Saluggia, VC 13040, IT.
-
How many shares of DSRLF are traded daily?
-
The average number of DSRLF shares traded daily for last 3 months was 116.
-
What is the market cap of DSRLF currently?
-
The market value of DSRLF currently stands at $4.01B with its latest stock price at $81